Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2

British Journal of Pharmacology

Volumn 131, Issue 8, 2000, Pages 1521-1530

  Hirata, Akihiko ^a   Igarashi, Masahiko ^a   Yamaguchi, Hiroshi ^a   Suwabe, Akira ^a   Daimon, Makoto ^a   Kato, Takeo ^a   Tominaga, Makoto ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Balloon catheterization; ERK 1 2; Intimal thickening; Nifedipine; PCNA; PTCA; Pyk2; Rat; Vascular smooth muscle cell

Indexed keywords

CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; CONTROLLED STUDY; DRUG EFFECT; ENZYME REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0034528377     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703730     Document Type: Article

References (46)

1. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
2. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
3. Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic β cell line
4. The calcium antagonist nifedipine stimulates endothelial NO release in therapeutical concentrations
5. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells
6. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
7. Antiatherosclerotic activity of drugs in relation to nitric oxide function
8. Repeated balloon injury of rat aorta. A model of neointima with attenuated inhibition by heparin
9. Role of transactivation of EGF receptor in signaling by G-protein-coupled receptors
10. Protective effect of nifedipine against cytotoxicity and intracellular calcium alterations induced by acetaminophen in rat hepatocyte cultures
11. Nifedepine: Dose-related increase in mortality in patients with coronary heart disease
12. β-Chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK
13. Shanghai trial of nifedipine in the elderly (STONE)
14. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures
15. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization
16. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
17. Mechanism of antiatherogenic action of calcium antagonists
18. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis
19. Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF β-receptor overexpression of aortic media
20. Effects of nicardipine on collar-induced intimal thickening and vascular reactivity in the rabbit
21. ++-induced regulation of ion channel and MAP kinase functions
22. Molecular bases of the acute coronary syndromes
23. Comparison of nifedipine, propranolol, and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris
24. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP) kinase cascades
25. Protein measurement with the folin phenol reagent
26. 2+-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype
27. Medical Research Council trial of treatment of hypertension in older adults: Principal results
28. Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison
29. National High Blood Pressure Education Working Group Report on hypertension in the elderly
30. Long-term survival and use of antihypertensive medications in older persons
31. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease
32. Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes
33. Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats
34. The pathogenesis of atherosclerosis - An update
35. Risk factors and their management for stroke prevention: Outlook for 1999 and beyond
36. The natural history of borderline isolated systolic hypertension
37. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium-channel antagonist
38. The MAPK signaling cascade
39. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of Systolic Hypertension in the Elderly Program (SHEP)
40. Diuretic therapy for hypertension and the risk of primary cardiac arrest
41. Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits
42. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: The Systolic Hypertension in Europe (Sys-Eur) Trial Investigators
43. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway
44. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
45. Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit
46. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats